| Literature DB >> 29998146 |
Yoshito Kamiya1,2, Satoru Ota1, Yuta Tanaka1, Kosuke Yamashita3, Akihiro Takaki3, Shigeki Ito4.
Abstract
OBJECTIVES: We recently developed a new uptake index method for 123I-metaiodobenzylguanidine (123I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). However, the diagnostic accuracy of the uptake index was approximately equal to that of the heart-to-mediastinum ratio (H/M) for the discrimination of the LBD and non-LBD patients. A simple and pain-free uptake index method using 123I-MIBG SPECT images by modifying the uptake index method may show better diagnostic accuracy than the planar uptake index method. We hypothesized that the development of a new uptake index method for the determination of 123I-MIBG using single-photon emission computed tomography (SPECT) imaging would provide a reliable and reproducible diagnostic tool for clinical application. Regarding this, the purpose of this study was to develop a new uptake index method with a simple protocol to determine 123I-MIBG uptake on SPECT.Entities:
Keywords: Iodine-123 metaiodobenzylguanidine; Lewy body disease; Quantification; Single-photon emission tomography
Year: 2018 PMID: 29998146 PMCID: PMC6038978 DOI: 10.22038/aojnmb.2018.10595
Source DB: PubMed Journal: Asia Ocean J Nucl Med Biol ISSN: 2322-5718
Figure 1Region of interest (ROI) settings and typical time-activity curves of the pulmonary artery
Figure 2Region of interest setting and image reconstruction for the low 123I-MIBG uptake images
Characteristics of the subjects
|
|
|
|
|
|---|---|---|---|
| Sex (M/F) | 17/20 | 20/20 | 0.821 |
| Age (y) | 75.0±7.6 (range 57-89) | 74.4±7.7 (range 56-92) | 0.934 |
Fisher’s exact test.
Clinical diagnoses of the subjects
|
|
| ||
|---|---|---|---|
| PD | 27 | AD | 8 |
| DLB | 10 | VPS | 13 |
| DPS | 9 | ||
| Other | 10 | ||
| Total | 37 | 40 | |
LBD: Lewy body disease
DLB: Dementia with Lewy bodies
PD: Parkinson’s disease
AD: AD with parkinsonism
VPS: Vascular parkinsonism
DPS: Drug-induced parkinsonism
Figure 3.Correlation between the mean planar mean counts and SPECT counts
Figure 4Correlation between heart-to-mediastinum ratio and uptake index percentage
Figure 5Comparison of the Lewy body disease and non-Lewy body disease groups in terms of the values obtained from each method
Figure 6Receiver-operating characteristic (ROC) curves
Comparison of diagnostic accuracy (n=77)
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| H/M | 0.93 | 0.84 | 0.95 | <2.21 | 0.84 - 0.97 | 0.94 | 0.86 | 0.90 |
| Planar uptake index | 0.94 | 0.81 | 0.93 | <1.1 | 0.85 - 0.98 | 0.91 | 0.84 | 0.87 |
| SPECT uptake index | 0.96 | 0.86 | 1.00 | <1.2 | 0.86 - 0.99 | 1.00 | 0.89 | 0.94 |
AUC, area under the curve; 95% CI, 95% confidence interval.
H/M, heart to mediastinum ratio.
PPV, positive predictive value;
NPV, negative predictive value.